An
bio
Anbio Biotech
HOME
PRODUCT
PARTNER WITH US
ABOUT ANBIO
NEWSROOM
Releases
Events
CONTACT
DIAGNOSTICS BEYOND
The healthcare landscape is evolving.
We advance diagnostics by providing
accessible and affordable diagnostic
solutions at the forefront of science.
THE HEALTHCARE LANDSCAPE IS EVOLVING
Patient Healthcare
Increasing importance of Chronic Disease Management
Declining Population Health
More focus on Precision Medicine
High Demand for In-vitro Diagnostics
WE IMPROVE HEALTHCARE BY DECENTRALIZATION
In the past, diagnostic process can take up to
14 days
or longer
Patient
Healthcare Professional ( HCP)
Patient goes to lab / clinic to get tested
Picked by courier
Goes to central laboratory
Data generated
Back to HCP
With our diagnostic solutions, this process is
shorten to less than
1 day
, as little as just
1 hour
to diagnosis.
Patient
Healthcare Provider (Doctor)
Sample
LAB
Sample collection and onsite testing
Doctor talking to patient
WE ARE A DIAGNOSTICS SOLUTIONS PROVIDER
Anbio’s Fluorescent
Immunochromatographic
Solution
(FIA)
Portable analyzer solution with 83 available assays, suitable for laboratory, wellness, and point-of-care applications.
Learn More
Anbio’s Chemiluminescent
Immunoassay Solution
(ChLIA)
Learn More
Anbio’s Molecular
Solution
(RT-PCR)
25 available assays suitable for laboratory applications.
Learn More
Anbio’s
Lateral Flow Immunoassay
(Colloidal Gold) Solution
(LFIA)
62 available assays suitable for point-of-care and at-home applications.
Learn More
Anbio’s
Loop-Mediated Isothermal
Amplification Solution
(LAMP)
Detect nucleic acid markers with high accuracy. Suitable for point-of-care and at-home applications.
Learn More
OUR COMPREHENSIVE PORTFOLIO OF TESTS
CANCER
We have 34 total cancer assays available for FIA, ChLIA, LFIA(CG) and Molecular platforms.
CARDIOVASCULAR
We have 23 total cardiovascular assays available for FIA, LFIA(CG), and ChLIA platforms.
HORMONES
We have 36 total hormones assays available for FIA, ChLIA, and LFIA(CG) platforms.
INFECTIOUS DISEASES
We have 65 total infectious diseases assays available for LAMP, FIA, LFIA(CG), and Molecular platforms.
INFLAMMATION
We have 9 total inflammation assays available for ChLIA and FIA platforms.
DRUG OF ABUSE
We have 37 total Drug of Abuse assays available for FIA and LFIA(CG) platforms.
PRODUCT
PARTNER WITH US
ABOUT ANBIO
NEWSROOM
CONTACT
Private Policy
© Copyright 2024 Anbio Biotechnology Inc. All rights reserved.
PRODUCT
PARTNER WITH US
ABOUT US
NEWSROOM
CONTACT
Private Policy
© Copyright 2023
Anbio Biotechnology Inc. All rights reserved.
Anbio Biotech
HOME
PRODUCT
PARTNER WITH US
ABOUT ANBIO
NEWSROOM
Releases
Events
CONTACT
DIAGNOSTICS
BEYOND
The healthcare
landscape is evolving.
We advance diagnostics
by providing accessible
and affordable diagnostic
solutions at the forefront
of science.
THE HEALTHCARE LANDSCAPE IS
EVOLVING
Patient Healthcare
Increasing importance of Chronic Disease Management
Declining Population Health
More focus on Precision Medicine
High Demand for In-vitro Diagnostics
WE IMPROVE HEALTHCARE BY
DECENTRALIZATION
In the past, diagnostic process can take up to
14 days
or longer
Patient
Healthcare Professional ( HCP)
Patient goes to lab / clinic to get tested
Picked by courier
Goes to central laboratory
Data generated
Back to HCP
With our diagnostic solutions, this process is
shorten to less than
1 day
, as little as just
1 hour
to diagnosis.
Patient
Healthcare Provider (Doctor)
Sample
LAB
Sample collection and onsite testing
Doctor talking to patient.
WE ARE A DIAGNOSTIC SOLUTIONS
PROVIDER
Anbio’s Fluorescent
Immunochromatographic Solution
(FIA)
Portable analyzer solution with 83 available assays, suitable for laboratory, wellness, and point-of-care applications.
Anbio’s Chemiluminescent
Immunoassay Solution
(ChLIA)
Anbio’s Molecular Solution
(RT-PCR)
25 available assays suitable for laboratory applications.
Anbio’s Lateral Flow Immunoassay
(Colloidal Gold) Solution
(LFIA)
62 available assays suitable for point-of-care and at-home applications.
Anbio’s Loop-Mediated Isothermal
Amplification Solution
(LAMP)
Detect nucleic acid markers with high accuracy. Suitable for point-of-care and at-home applications.
OUR COMPREHENSIVE PORTFOLIO
OF TESTS
CANCER
We have 34 total cancer assays available for FIA, ChLIA, LFIA(CG) and Molecular platforms.
CARDIOVASCULAR
We have 32 total cardiovascular assays available for FIA, LFIA (CG), and ChLIA platforms.
HORMONES
We have 36 total hormones assays available for FIA, ChLIA, and LFIA(CG) platforms.
INFECTIOUS DISEASES
We have 65 total infectious diseases assays available for LAMP, FIA, LFIA(CG), and Molecular platforms.
INFLAMMATION
We have 9 total inflammation assays available for ChLIA and FIA platforms.
DRUG OF ABUSE
We have 37 total Drug of Abuse assays available for FIA and LFIA(CG) platforms.
PRODUCT
PARTNER WITH US
ABOUT ANBIO
NEWSROOM
CONTACT
Private Policy
© Copyright 2024 Anbio Biotechnology Inc. All rights reserved.
PRODUCT
PARTNER WITH US
ABOUT US
NEWSROOM
CONTACT
Private Policy
© Copyright 2023
Anbio Biotechnology Inc. All rights reserved.